A trial for a COVID-19 vaccine at Oxford University for AstraZeneca has resumed, according to a report from the Wisconsin State Journal.
The study was suspended after a reported side effect in a UK patient. The University of Wisconsin–Madison has been identified as a testing site for 1,600 subjects. Globally, more than 18,000 volunteers have received the vaccine. Enrollment for the UW study remains paused.
